A team of researchers from UMBC is developing a new, low-cost anti-malarial drug to help tackle a disease that causes over 200 million infections and 400,000 deaths annually, according to the World Health Organization (WHO).
Post Info
| posted | July 23, 2018 |
|---|---|
| sponsor | Corporate and Foundation Relations |
| tags | cbeecfrcoeitscience-and-technology |
| share |
|
Recent Posts
-
Posted about 6 years ago
-
Posted about 6 years ago
-
Posted over 6 years ago
-
Posted almost 7 years ago
-
Posted almost 7 years ago
myUMBC is a UMBC limited public community forum for information sharing and dialogue. As a public institution, UMBC generally may not limit a community member's right to free speech on this forum. UMBC does not endorse the views expressed or information presented here, unless specifically stated in an official UMBC post. Learn more...